G. Bothamley (London, United Kingdom), S. Tiberi (London, United Kingdom)
Clinical characteristics of pulmonary tuberculosis in elderly Japanese patients
M. Marukawa (Marugame, Japan), K. Matsuoka (Marugame, Japan), H. Higo (Marugame, Japan), N. Suzaki (Marugame, Japan), T. Nagata (Marugame, Japan)
|   |
Detection of NTM in surgery samples from patients hospitalized with presumed TB
T. Smirnova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), S. Andreevskaya (Moscow, Russian Federation), I. Andrievskaya (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation)
| |
The change of PD-1 and CTLA-4 during LTBI and TB reactivation
C. Shu (Taipei, Taiwan)
| |
The Pleural and blood gene expression level of GBP5 and STAT1 were associated with pleural tuberculosis: TB pleura diagnostic biomarkers.
N. Luekitinun (Bangkok, Thailand), S. Mahasirimongkol (Nonthaburi, Thailand), N. Satproedprai (Nonthaburi, Thailand), R. Miyahara (Nonthaburi, Thailand), K. Kawkitinarong (Bangkok, Thailand)
| |
Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis
T. Akamatsu (Shizuoka, Japan), T. Shirai (Shizuoka, Japan), K. Tamura (Shizuoka, Japan), T. Masuda (Shizuoka, Japan), S. Takahashi (Shizuoka, Japan), Y. Tanaka (Shizuoka, Japan), Y. Kishimoto (Shizuoka, Japan), K. Oishi (Shizuoka, Japan), Y. Endo (Shizuoka, Japan), M. Saigusa (Shizuoka, Japan), A. Yamamoto (Shizuoka, Japan), S. Morita (Shizuoka, Japan), K. Asada (Shizuoka, Japan)
| |
Comparison of utilizing GeneXpert MTB/RIF and other conventional methods on bronchoalveolar lavage in the diagnosis of Mycobacterium tuberculosis: A real-life retrospective study
C. Soo (Kuala Lumpur, Malaysia), K. Lim (Kuala Lumpur, Malaysia), R. Rajah (Kuala Lumpur, Malaysia), B. Ng (Kuala Lumpur, Malaysia), F. Abdul Hamid (Kuala Lumpur, Malaysia), A. Ban (Kuala Lumpur, Malaysia)
| |
Detection of metabolic profile in urine for diagnosing pediatric tuberculosis
P. Comella-del-Barrio (Badalona, Spain), J. Izquierdo-Garcia (San Sebastián, Spain), R. Campos-Olivas (Madrid, Spain), C. Santiveri (Madrid, Spain), J. Ruiz-Cabello (San Sebastián, Spain), T. Pérez-Porcuna (Terrassa, Spain), J. Domínguez (Badalona, Spain)
| |
Sensitivity and specificity of loop-mediated isothermal amplification assay for diagnosis of extra-pulmonary tuberculosis: A cross-sectional study
P. Singh (Mumbai, India), S. Kanade (Mumbai, India), G. Nataraj (Mumbai, India)
| |
Prospective validation of a proposed severity-of-illness score in patients with tuberculosis requiring intensive care unit admission
C. Koegelenberg (Cape Town, South Africa), U. Lalla (Cape Town, South Africa), J. Taljaard (Cape Town, South Africa), B. Allwood (Cape Town, South Africa), E. Irusen (Cape Town, South Africa)
| |
Outcomes of new entrant TB screening in Bolton, UK
G. Katzenberg (Bolton, United Kingdom), R. Ahmed (Bolton, United Kingdom)
| |
New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach
p. van der Valk (Enschede, Netherlands), R. Van Crevel (Nijmegen, Netherlands), J. Jde Steenwinkel (Rotterdam, Netherlands), M. Bakker (Nijmegen, Netherlands), H. Vonkeman (Enschede, Netherlands), R. Van Hest (Groningen, Netherlands)
| |
Combined evaluation of TBAg/M, IL22 and IL17 to predict LTBI progression
Y. Todorova (Sofia, Bulgaria), R. Emilova (Sofia, Bulgaria), V. Milanov (Sofia, Bulgaria), E. Bachiyska (Sofia, Bulgaria), Y. Atanasova (Sofia, Bulgaria), T. Varleva (Sofia, Bulgaria), L. Eneva (Sofia, Bulgaria), M. Nikolova (Sofia, Bulgaria)
| |
Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania
E. Grønningen (Bergen, Norway), L. Sviland (Bergen, Norway), E. Ngadaya (Dar es Salaam, Tanzania), M. Nanyaro (Dar es Salaam, Tanzania), W. Muller (Dar es Salaam, Tanzania), L. Torres (Dar es Salaam, Tanzania), S. Mfinanga (Dar es Salaam, Tanzania), T. Mustafa (Bergen, Norway)
| |
The meaning of a high monocyte to lymphocyte ratio in tuberculosis
T. Buttle (London, United Kingdom), G. Bothamley (London, United Kingdom)
| |
Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection
K. Jo (Seoul, Republic of Korea), O. Kim (Seoul, Republic of Korea), S. Park (Gangneung, Republic of Korea), Y. Jo (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), H. Sung (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea)
| |
Evaluation of IP-10 in blood serum for TB diagnosis in patients with late-stage HIV infection
A. Dudchenko (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), M. Averbakh (Moscow, Russian Federation), A. Ergesho (Moscow, Russian Federation)
| |